Shenzhen Neptunus Interlong Bio-technique Dividends and Buybacks
Dividend criteria checks 0/6
Shenzhen Neptunus Interlong Bio-technique does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Buyback Yield
Total Shareholder Yield | n/a |
Future Dividend Yield | n/a |
Dividend Growth | n/a |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Using Too Much Debt?
Nov 07Shenzhen Neptunus Interlong Bio-technique Company Limited's (HKG:8329) Share Price Is Matching Sentiment Around Its Earnings
Sep 05We Think You Can Look Beyond Shenzhen Neptunus Interlong Bio-technique's (HKG:8329) Lackluster Earnings
Apr 19These 4 Measures Indicate That Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Is Using Debt Safely
Oct 03Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) A Risky Investment?
Mar 29We Think Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Can Stay On Top Of Its Debt
Sep 28A Look At The Intrinsic Value Of Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)
Aug 18Does Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Have A Healthy Balance Sheet?
Jun 06Is Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Using Too Much Debt?
Dec 15Shenzhen Neptunus Interlong Bio-technique's(HKG:8329) Share Price Is Down 49% Over The Past Five Years.
Dec 29Shenzhen Neptunus Interlong Bio-technique (HKG:8329) Seems To Use Debt Rather Sparingly
Nov 24Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if 8329's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 8329's dividend payments have been increasing.
Dividend Yield vs Market
Shenzhen Neptunus Interlong Bio-technique Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (8329) | n/a |
Market Bottom 25% (HK) | 3.0% |
Market Top 25% (HK) | 7.9% |
Industry Average (Pharmaceuticals) | 3.6% |
Analyst forecast (8329) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate 8329's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 8329's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate 8329's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as 8329 has not reported any payouts.